Cidara Therapeutics’ REZZAYO bags UK and EU approvals in invasive candidiasis

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company focused on developing life-saving therapies, announced a significant breakthrough with the United Kingdom (U.K.) Medicines and Healthcare ... Read More